ARTICLE | Product Development
AbCellera, Vir find partners for COVID-19 mAb manufacturing capacity
Two start-ups partner for COVID-19 mAb manufacturing muscle
March 14, 2020 3:11 AM UTC
The race to create antibody-based treatments for COVID-19 gained momentum this week as two start-ups linked up with biopharma companies for mAb development expertise and manufacturing capacity.
Eli Lilly and Co. (NYSE:LLY) will co-develop antibodies discovered by AbCellera Biologics Inc., and Biogen Inc. (NASDAQ:BIIB) will manufacture antibodies from Vir Biotechnology Inc. (NASDAQ:VIR)...